Dexmedetomidine attenuates acute paroxysmal sympathetic hyperactivity

We evaluated the curative effect of dexmedetomidine on paroxysmal sympathetic hyperactivity (PSH) in a retrospective study of 72 PSH patients after neurosurgery. Our results showed that dexmedetomidine was superior to propofol for treatment of PSH with respect to: average time needed to reduce parox...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Yuan, Zhu, Haifeng, Chen, Haodong, Zhu, Zijin, Zhou, Huahai, Zhang, Shuguang, Gao, Lili, Shi, Lei, Li, Xiaoliang, Luo, Zhengxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620316/
https://www.ncbi.nlm.nih.gov/pubmed/28978176
http://dx.doi.org/10.18632/oncotarget.16920

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620316/
https://www.ncbi.nlm.nih.gov/pubmed/28978176
http://dx.doi.org/10.18632/oncotarget.16920

Ejemplares similares